• Keynotes Speakers

    Dr. Zaida Alvarez
    Dr. Zaida Alvarez is currently a Ramon y Cajal and leading investigator of the biomaterials for neural regeneration group at the Institute for Bioengineering of Catalonia (IBEC), Spain. She earned her PhD degree in Biomedical Engineering with Prof. Elisabeth Engel at Polytechnic University of Catalonia in 2014. In 2015, as a self-funded postdoc she joined Professor Samuel Stupp’s laboratory, at Northwestern University in Chicago to work on peptide amphiphiles for neural regeneration where she published more than 15 papers in high impact factor journals such as Science, Nature nanotechnology, nature communications, Advanced Science or Nanoletters. In 2019, she was promoted as an assistant professor at the department of medicine, at Feinberg Medical school at Northwestern University where she continued her research in spinal cord regeneration and in vitro platforms for iPs modelling. She is also consulting engineering in a couple of companies in the USA, she has 4 patents already transferred to AmphixBio Incorporation and got numerous awards such as Young Baxter investigator award in 2019, and Rafael Hervada award in 2021.
    Dr. Maria Asplund

    Dr. Maria Asplund is heading the research group "Bioelectronic Microtechnology" at the University of Freiburg, Germany. She develops micro-devices for future bioelectronic medicine, with applications ranging from artificial vision via implantable brain interfaces, to tissue regeneration of skin and spinal cord. Her work contributes to making future bioelectronics smaller, more energy efficient, and seamlessly integrated with biological tissue. With a background in Applied Physics and Electrical Engineering (MSc, Linköping University 2003) and a PhD from the Royal Institute of Technology (Stockholm, 2009) she started her own research group in Freiburg as a Junior Fellow of Freiburg Institute for Advanced Studies (FRIAS) in 2011, and continued as a junior group leader with the Cluster of Excellence BrainLinks-BrainTools. In 2017, she was awarded with an ERC Starting Grant for her development of an electroactive wound dressing. Since 2019 she is, in addition to her position in Freiburg, appointed as guest professor at the Luleå University of Technology, Sweden and is furthermore appointed as Senior Fellow of FRIAS.
    Dr. Emilie Attiogbe
    Passionate about tissue engineering, Emilie Attiogbe has completed a bachelor and master degree in biochemistry and biomaterials for health as well as an engineering degree at university de Cergy Pontoise (France). Currently a third year PhD student in the laboratory of Pr Véronique Moulin, she is working on the development of an immunocompetent skin model for the study of human wound healing in the Laboratory of experimental organogenesis LOEX (Québec, Canada). A curious person, Emilie is always looking for new challenges. She likes to share science with the community and is involved in various scientific popularization activities. She is also involved in a network in the province of Quebec that brings together students working on stem cells. Willing to be a difference-maker, she also participates in a student venture capital project that aims to invest in the best student high-tech start-ups. 
    Dr. Irem Bayindir-Buchhalter
    Irem Bayindir-Buchhalter, Editor-in-Chief of Advanced NanoBiomed Research, studied Molecular Biology and Genetics at the Middle East Technical University, Ankara. She focused on hematopoietic differentiation of embryonic stem cells during her MSc at Heidelberg University and the German Cancer Research Center (DKFZ). She obtained her PhD working on adipose tissue plasticity and metabolic homeostasis at the same institute. Her passion for science communication and strong interest in continuous learning led Irem to apply for a position in scientific editing at Wiley-VCH. She is based in Weinheim working as a peer review editor for Advanced family of journals
    Dr. Christophe Bureau
    Dr. Christophe Bureau obtained his Ph.D in Quantum Physics at Ecole Normale Supérieure in Paris, “Xtof” spent 10 years at the French Atomic Energy Commission (CEA), where he invented a process to coat metals with nanometric polymer brushes, termed “electro-grafting” (eG™). He spun-off in 2007 to create AlchiMedics, raising a total of 12M€ from venture capital. AlchiMedics was acquired in 2012 by Sinomed, a Chinese unicorn in interventional cardiology, neurology and structural heart, listed on the Shanghai stock exchange (688108.SH). As of 2022, more than 1 million patients are implanted worldwide with the BuMA™, HT Supreme™ and NOVA™ stents bearing the eG™ technology, which promotes early re-endothelialization in interventional cardiology and neurology procedures. Since 2019, Xtof is also Vice-President of Strategic Innovation at Sinomed
    Dr. Caroline Caradu
    Dr. Caroline Caradu obtained her M.D. in 2015 by defending a thesis on the comparison of F-EVAR and Ch-EVAR in complex aortic aneurysms. She then obtained her specialty degree in vascular surgery in 2018 and her Ph.D. in 2020 in collaboration with the Inserm unit 1034, by defending a thesis on the role of endothelial cell dysfunction in the pathophysiology of CLTI. She holds university degrees in ultrasound techniques, wound healing and endovascular surgery. She completed the majority of her training at the Bordeaux University Hospital in the vascular surgery department of Prof. Eric Ducasse and she is a former Fellow of London St Mary's Hospital. Her research interests include therapeutic approaches to CLTI, endothelial dysfunction, complex aortic aneurysms, vascular graft and endograft infections and the implication of A.I. in the field of vascular pathology.
    Pr. Gianni Ciofani
    Pr. Gianni Ciofani is Senior Researcher Tenured at the Istituto Italiano di Tecnologia (IIT), where he is Principal Investigator of the Smart Bio-Interfaces Research Line and Coordinator of the Center for Materials Interfaces (Pontedera, Italy). His main research interests are in the field of smart nanomaterials for nanomedicine, bio/non-bio interactions, and biology in altered gravity conditions. He is coordinator or unit leader of many grants/projects, and he was awarded a European Research Council (ERC) Starting Grant and an ERC Proof-of-Concept Grant in 2016 and 2018, respectively. Gianni Ciofani is author of about 160 papers on international journals, 3 edited books, and 16 book chapters, and delivered about 50 invited talks/lectures in international contexts. He serves as Editorial Board Member of Nanomedicine UK, Scientific Reports, International Journal of Nanomedicine, Journal of Physics: Materials, and Bioactive Materials. He is Specialty Chief Editor (Nanobiotechnology) for Frontiers in Bioengineering and Biotechnology.
    Pr. Magali Cucchiarini
    Pr. Magali Cucchiarini, Group Leader, and Vice-Director of the Center of Experimental Orthopaedics at Saarland University Medical Center (Germany). She graduated from the University of Nice-Sophia Antipolis where she received her PhD Thesis with summa cum laude. She was a senior post-doctoral fellow at Harvard Medical School and worked at the University Hospital Inselsspital (Switzerland). Her major research interest lies in generating novel cell-, gene-, and tissue engineered-based systems to treat orthopaedic disorders. She made over 138 national and international presentations, co-authored 13 books chapters and edited one book (Regenerative therapy for the musculoskeletal system using recombinant adeno-associated viral vectors), and is an author of over 185 peer-reviewed articles. She sits on the Editorial Boards for OAC Open, Journal of Experimental Orthopaedics, BioMed Research International, and OJSM. She serves as a Board Member of the OARSI, was a Board Member of the ORS and is involved at the ICRS and American Society of Gene & Cell Therapy.
    Pr. Paolo Decuzzi
    Pr. Paolo Decuzzi is a Senior Scientist and Professor of Biomedical Engineering at the Italian Institute of Technology (IIT). In 2015, he founded the Laboratory of Nanotechnology for Precision Medicine after 10 years of activities conducted in different Clinical Research Institutions in Houston (USA). He is a board member of multiple scientific associations, institutions, and advisory panels, including the Controlled Release Society, IIT, ERC, and the biotech accelerator program SPARK at Stanford. His multidisciplinary research focuses on the rational design of nanoconstructs and implantable devices for the treatment and imaging of various diseases (cancer, cardiovascular and chronic inflammatory diseases), the development of AI-based models for optimizing the therapeutic efficacy of drug delivery systems. In this context, he has published more than 200 scientific contributions and generated more than 10 patents. His activities have been funded by multiple organizations, in the US and EU, and private companies totaling over $15 million.
    Dr. Miguel Dias Castilho
    Dr. Miguel Dias Castilho is a tenured Assist. Prof. at the Eindhoven University of Technology and holds an adjunct appointment at the University Medical Center Utrecht, The Netherlands. His research is focused on design and processing of biomaterials that can instruct functional restoration of damaged& diseased tissues, with a particular focus on mineralized tissues. He authored more than 50 publications in peer-reviewed journals and is currently supervising 5 PhD students and 1 post-doc fellow. He is involved in the EU-funded H2020 project BRAV3 (874827) as a WP co-leader and expert on 3D printing and design of microfiber polymeric scaffolds, and as PI in the Eurostars - CHIRON project (E!114399) focusing on development of bioactive bone substitutes. For his contributions on 3D printing for regenerative medicine, he was conferred several awards, including the 2017 Wake Forest Institute Young Scientist Award and the 2021 innovation in Biofabrication award. Since the start of his academic trajectory, he has been able to secure competitive national and international consortium grants
    Dr. Agnes Dobos 
    Dr. Agnes Dobos earned her BSc in Biochemical Engineering at the Technical University of Budapest in 2014. She continued her studies in Sweden and Austria and received MSc double degree in Tissue Engineering and Medical Biosciences at FH Wien and the University of Linköping in 2016. She joined the Ovsianikov Lab at the Vienna University of Technology (TU Wien) in 2016 where she is pursued her PhD in the field of multiphoton lithography. She has employed this technology to enable high resolution fabrication of biomimetic in vitro models for organ-on-chip applications. After her PhD she joined the group of Prof Sandra Van Vlierberghe at University of Ghent as a postdoc where she was working on a project to turn the biofabrication technology into reality via the launch of the spin-off company BIO INX where she is a cofounder as application specialist. Her research interests lie in the area of biofabrication and organ-on-chip devices.
    Dr. Rui M. A. Domingues
    Dr. Rui M. A. Domingues is a Senior Researcher and Invited Assistant Professor at I3Bs – Research Institute for Biomaterials, Biodegradables and Biomimetics, University of Minho, Portugal. He holds a PhD in Chemical Engineering from the University of Aveiro (Portugal), and has studied and worked at different institutions in Europe and US, namely Institute of Chemical Technology (Czech Republic), ENCE (Spain) and University of Texas at Austin (US). His research has focused on the development of functional biomaterials and biofabrication concepts for tissue engineering and regenerative medicine applications (TERM). His main research interest is on exploring different types of nanoparticles, in particular cellulose nanocrystals, magnetic and molecularly imprinted nanoparticles to produce nanostructured biomaterials with biomimetic features to control cell fate in TERM strategies. During his career he has widely applied these concepts on the development of bioengineered systems, particularly targeting tendon tissue regeneration and in vitro modeling.
    Dr. Audrey Ferrand
    Dr. Audrey Ferrand obtained in 2004 a PhD in Pharmacology from the University of Toulouse. Her research interest in the laboratory of Digestive Biology (INSERM U531) was to decipher the signaling pathways involved in the initiation of colon and pancreas cancers. In 2005, she joined the laboratory of Jeffrey Settleman at theMassachusetts General Hospital (MGH) Cancer Center (Harvard Medical School,USA) where she characterized the differential drug response of mutated EGFR in non-small cell lung cancer. In 2006, shemoved to the University of Melbourne (Australia) where she identified the crucial role of gastrin precursors in the tumor-initiating capacity of CD133-positive colon cancer cells. In 2009, she has been recruited as a junior assistant professor (INSERM CRCN) to establish a research program aiming to identify therapeutic targets in colorectal. Since 2018, she leads a research group at the Institut de Recherche en Santé Digestive studying the interactions between the intestinal epithelium and the environment.
    Dr. Albina R. Franco 
    Dr Albina R. Franco is a Researcher at the I3Bs Research Institute of the University of Minho (Portugal). She obtained her PhD (Biotechnology) in 2014 from the Portuguese Catholic University. Her search for better Medical Healthcare has driven her to pursue a career envisioning new solutions by engineering innovative biomaterials for tissue engineering and stem cell differentiation. Her research is currently focused on the exploitation of new recombinant proteins for different biomedical applications, in particular designing new drug-free materials using bioengineered spider silk polymers incorporating different bio-instructive and functional domains (antimicrobial, tenogenic). She has over 35 peer-reviewed publications with over 555 citations.
    Pr. Julien Gautrot
    Pr. Julien Gautrot is Professor in Biomaterials and Biointerfaces in the School of Engineering and Materials Science and Engineering at Queen Mary, University of London. His research focuses on the development of biointerfaces and microengineered biomaterials for stem cell technologies and the design of advanced cell culture platforms. In particular, his group has been exploring the physico-chemical properties of polymer brushes, the regulation of interactions of biomacromolecules at these interfaces and pioneered their application for the design of stem cell microarrays and for gene delivery. He has published over 90 research articles, including in journals such as Chem. Rev., Nat. Mater., Nat. Cell Biol., Nat. Commun., Angew. Chem. Int. Ed., ACS Nano, Advanced Functional Materials and Nano Letters. In 2017, he was awarded an ERC consolidator grant to explore the design of bioemulsions for stem cell technologies. Since 2021, he is Director of the CDT in Molecular Biochemical Engineering at QMUL
    Pr. Ronette Gehring
    Pr. Ronette Gehring is Professor and Chair of Veterinary Pharmacotherapeutics and Pharmacy at Utrecht University (The Netherlands). Her research focuses on the use of mechanistic mathematical models to analyze, interpret and extrapolate pharmacological and toxicological data with an emphasis on understanding intra- and inter-species differences in kinetics and dynamics. She is also interested in exploring ways to reduce the use of animals in biomedical research through replacement with in vitro and in silico models. She has (co-) authored more than 100 peer-reviewed scientific publications and contributed book chapters to several veterinary textbooks. She is a diplomate of the American College of Veterinary Clinical Pharmacology (ACVCP) and the European College of Veterinary Pharmacology and Toxicology (ECVPT), and is currently serving on the steering committee of VetCAST.
    Pr. Manuela E. Gomes
    Pr. Manuela E. Gomes is Associate Professor and President of the I3Bs Research Institute of the University of Minho (Portugal). Her research interests currently focus on tendon tissue engineering strategies, namely in the development of scaffold materials and bioinks based on biodegradable natural origin polymers, stem cells sourcing and differentiation (using biochemical and physical methods). She has been involved in numerous European and national/regional projects as PI or team member. She currently coordinates a Consolidator Grant from the European Research Council (ERC CoG, MagTendon) and a EC funded Twinning Project (Achilles). She is editor 2 books and co-editor of the Tissue Engineering Encyclopaedia (Elsevier, 2019) and author of 225 full papers, 45 book chapters, 8 patents and has delivered more than 50 lectures in international conferences. Her work has been cited more than 10.706 times, with an h-index of 55 (Scopus).
    Pr. Sei Kwang Hahn 
    Sei Kwang Hahn is the SeokCheon Chair Professor in the Department of Materials Science and Engineering at POSTECH. He obtained his B.S. (1991), M.S. (1993) and Ph.D. (1996) at KAIST. He did his post-doctoral research with Prof. Allan Hoffman at the University of Washington for 2001-2002. After that, he worked at the Hoffman-La Roche group, Chugai Pharmaceutical Co. in Japan for 2002-2005. Since 2005, he has worked as a professor at POSTECH. He was a visiting professor at Harvard Medical School for 2012-2013 and at Stanford University for 2019-2020. He won the prestigious Song-Gok Science and Technology Award in 2022, the Controlled Release Society Award in 2018, the Minister of Health and Welfare Award in 2017, and the Korean President Award in 2015. He was the Samsung Future Technology Committee, the Presidential Advisory Council on Science and Technology, and is the National Academy of Engineering Korea. He is the editorial board member of ACS Biomaterials Science and Engineering, ACS Applied Bio Materials, Biomacromolecules, the associate editor of Biomaterials Research, and the Guest Editor of APL Materials and Advanced Drug Delivery Reviews.
    Dr. Christophe Hélary
    Dr. Christophe Hélary got his Ph.D degree in Tissue Engineering and Biomaterials from Sorbonne University, Paris, France in 2010. In 2012, he became a research engineer at Laboratory of Condensed Matter Chemistry of Paris (LCMCP). The Christophe’s research activities in the past 10 years have been focused on the development of dense collagen hydrogels for biomedical applications. He uses collagen in dense phase to improve stability, physical and mechanical properties of hydrogels. Since 2013, his research orientation is towards the development of composite hydrogels to deliver biomolecules (drugs, therapeutic genes) in a controlled manner. He associates dense collagen with synthetic polymers (PLGA, PCL, PLA), natural polymers (alginate, hyaluronic acid), silica nanoparticles or hydroxyapatite. He has published 58 articles and is an inventor on 3 patents. He is a member of the Biohydrogel Society and BIOMAT, the french society for biomaterials.
    Dr. Andreas Lendlein
    Dr. Andreas Lendlein received his doctoral degree in Material Science from Swiss Federal Institute of Technology (ETH, Switzerland). His research interests comprise the creation of material functions by design and implementation of multifunctionality in polymer-based materials for biofunctional implants, controlled drug release systems, healthcare technologies and soft robotics. He published 745 papers, is an inventor on 338 issued patents and published patent applications in 63 patent families, and received 23 awards for his scientific work and his achievements as an entrepreneur. He is elected fellow of the Materials Research Society (2021), the American Institute for Medical and Biological Engineering (2021) & the Controlled Release Society (2020), founding Editor-in-Chief of the journal Multifunctional Materials and serves on the Executive Advisory Board of Wiley-VCH´s Macromolecular Journals.
    Dr. Riccardo Levato
    Dr. Riccardo Levato is Associate Professor of Translational Bioengineering and Biomaterials at the Department of Clinical Sciences (Utrecht University), and at the Department of Orthopedics (University Medical Center), and Principal Investigator at the Regenerative Medicine Center. He worked in several research groups across Europe: 3Bs, University of Minho (Portugal); BioMatLab, Technical University of Milan (Italy), Institute for Bioengineering of Catalonia (IBEC, Spain), and he holds a cum laude PhD in Biomedical Engineering from IBEC and the Technical University of Catalonia. In 2020 he was awarded a Starting grant from the ERC on the development of a novel volumetric bioprinting technology for organoid research and to engineer functional bone marrow analogues in vitro. Since 2021, he is coordinator of a European consortium (ENLIGHT), on biofabricated pancreas to study treatments for diabetes.  He published more than 55 papers, and he was conferred several awards including the 2016 Wake Forest Institute for Regenerative Medicine Young Investigator Award, and the 2021 Jean Leray award from the European Society for Biomaterials.
    Pr. João F. Mano
    Pr. João F. Mano is a full professor at the Department of Chemistry of the University of Aveiro (Portugal). He is vice-director of CICECO – Aveiro Institute of Materials where he is directing the COMPASS Research Group (compass.web.ua.pt). His current research interests include the use of biomaterials and cells towards the development of multidisciplinary concepts especially aimed at being used in regenerative and personalised medicine. He is the Editor-in-Chief of Materials Today Bio (Elsevier). He has been coordinating several national and European research projects, including two advanced grants from the European Research Council. João F. Mano has received different honours and awards, including two honoris causa doctorates (Univ. of Lorraine and Univ. Utrecht) and was elected fellow of the European Academy of Sciences (FEurASc), Biomaterials Science & Engineering (FBSE) and American Institute of Medical and Biological Engineering (FAIMBE).
    Dr. Christophe Marquette
    Dr. Christophe Marquette received the Doctorat de spécialité in Biochemistry (1999) from the Université Claude Bernard-Lyon 1. After a two years post-doctoral fellowship at the Concordia University (Canada, Qc), he integrated the Centre National de la Recherche Scientifique (CNRS) in 2001. He is presently permanent Research Director and Deputy Director at the Institut de Chimie et Biochimie Moléculaires et Supramoléculaires (ICBMS, UMR5246, CNRS-Université Lyon1) and is in charge of the Biochips and Micro-arrays Group, dealing with biology/surface interaction and 3D printing of living cells. Since 1998, he is author or co-author of more than 150 articles (H index: 39), 15 book chapters, 18 patents and more than 120 communications. He is also the founder the Nano-H, AXO Science, HealShape and 3Deus Dynamics Companies. He is also the founder of the unique 3d.FAB platform, specialised in additive manufacturing technologies for Life Science (http://fabric-advanced-biology.univ-lyon1.fr/). 
    Pr. Lorenzo Moroni
    Pr. Lorenzo Moroni received his PhD cum laude in 2006 from Twente University on 3D scaffolds for osteochondral regeneration. In 2014 he joined Maastricht University, as a founding member of the MERLN Institute for Technology-Inspired Regenerative Medicine. In 2016, he became full professor in biofabrication for regenerative medicine, and is chair of the Complex Tissue Regeneration Department and director of MERLN. His research group aims at developing biofabrication technologies to control cell fate, with applications spanning from skeletal to vascular, neural, and organ regeneration.
    Dr. Erik Nilebäck
    Dr. Erik Nilebäck is a senior application scientist at Biolin Scientific and has been active in the world of surface science, life science and innovation for over 15 years. He has a PhD in bioscience from Chalmers University of Technology in Sweden on the topic “QCM-D – With Focus on Biosensing in Biomolecular and Cellular Systems” following his MSc studies in Engineering Biology at Linköping University. Biomaterials is the scientific area that sparked Erik’s interest for research and during his PhD project he studied how QCM-D can be used to study specificity in enzyme- and/or cell-carbohydrate interactions relevant for tissue engineering. Today, in the application development team at Biolin Scientific, Erik is providing technical expertise for the QSense product range to customers, colleagues and collaborators.
    Dr. Jos Olijve
    Dr Jos Olijve is Scientific Support Manager at Rousselot and among others responsible for biomedical co-developments with academia, CRO’s, Institutes and customers. He is also involved in product developments and creating background knowledge on the behaviour of physical, chemical and purity properties of gelatin in various biomedical and pharmaceutical applications. Mr. Olijve has an educational background in biochemistry. Before joining Rousselot he worked for FujiFilm, where he was responsible for the development of photographic gelatins. He was also involved in the development of recombinant gelatin and gelatin based peptides for both photographic and biomedical applications. Dr. Olijve is the holder of 18 patents/patent applications, and (co-)author of 15 scientific papers.
    Dr. Valentina Onesto
    Dr. Valentina Onesto received a Master degree in Biomedical Engineering from the Polytechnic of Milan, Milan (Italy) and a PhD in biomedical, system and applied nanotechnologies engineering from University Magna Graecia, Catanzaro (Italy).  She has been a Visiting Researcher at the Italian Institute of Technology (IIT) of Genova (Italy) and a Visiting Research Associate at King’s College London, London (UK). From January 2019 she was a Senior Research Fellow Scientist at the CRIB@IIT of Naples (Italy). In September 2020 she started a Postdoctoral Researcher position at CNR‐Nanotec in Lecce (Italy) within the ERC‐Starting Project INTERCELLMED (No. 759959) and in July 2021 she became a Senior Postdoctoral Researcher in the same institute.
    Dr. Maria Pereira 
    Dr. Maria Pereira is a co-founder and Chief Innovation Officer at TISSIUM, a start-up focused on leveraging its polymer platform for atraumatic tissue reconstruction.  Maria holds a PhD in Bioengineering from the MIT-Portugal program and an MBA from INSEAD. She co-invented TISSIUM’s core technology during her PhD  studies in the laboratory of Prof. Jeff Karp, where she focused on the development of biomaterial-based solutions for unmet medical needs in the fields of tissue adhesion and drug delivery. Maria managed several multi-center collaborations leading to high impact publications in journals such as Science Translational Medicine and Advanced Materials. The first product from this core technology reached clinical stage in 2016. In 2014, she was named one of MIT Technology Review Magazine’s Innovators Under 35 Award and in 2015, she was recognized by Forbes Magazine as part of the 30 under 30 list in Healthcare.
    Dr. Massimo Perucca
    Dr. Massimo Perucca, MD Physics PhD in FluidDymamics, starting from fundamental research in fusion plasmas at MIT, Boston-MA, he devoted his efforts to the industrial applications of plasma technologies and nanotechnologies, targeting to safe and sustainable-by-design (SSbD) solutions. With more than 20 years’ experience in Life Cycle Assessment (LCA) Dr. Perucca is involved in the investigation of circular models for bio-based and nano-composite materials obtained by agro-forest and fish industry sidestreams. In 2005 he started the company Project HUB 360. Currently maintaining the role of co-owner and scientific manager, with the support of his team of ten experts, he is developing custom tools for sustainability assessment and multi-criteria decision quantitative models for SSbD decisions support tools. Since 2010 he is technical director of the Italian magazine “Trattamenti e Finiture”. He actively contributed to more than 20 European large research projects and several national and transnational projects; he counts several scientific and technical publications in plasma technology, nano-composite coatings, environmental and economic sustainability.
    Dr. Mauro Petretta 
    Dr. Mauro Petretta is the Senior Scientific Advisor at REGENHU and is responsible for the development of scientific applications using the bioprinting platform and for interactions with the scientific community. His work focuses on the processing of biomimetic and functionalized biomaterials, ranging from polymeric composites to cell-laden hydrogels, through additive manufacturing technologies for use in fields such as hard and soft tissue regeneration, drug discovery, personalized pharmaceuticals or bioelectronics. He brings years of research experience on tissue engineering and regenerative medicine combined with an in-depth know-how of REGENHU’s bioprinting platforms
    Dr. Jens Puschhof
    Dr. Jens Puschhof is group leader of the Epithelium Microenvironment Interaction Laboratory in the Microbiome and Cancer Division at German Cancer Research Center in Heidelberg, Germany. His group studies the role of microenvironmental factors in colorectal carcinogenesis using organoid- and organ-on-a-chip co-cultures. Dr. Puschhof graduated with a MSc in Oncology from the University of Oxford and obtained his PhD cum laude from Utrecht University. During his PhD and postdoc in Hans Clevers’s group at the Hubrecht Institute, he and his colleagues developed organoid models of the snake venom gland and made seminal contributions to the understanding microbial impacts on colorectal cancer development.
    Pr. John A. Rogers
    Pr. John A. Rogers obtained BA and BS degrees in chemistry and in physics from the University of Texas, Austin, in 1989.  From MIT, he received SM degrees in physics and in chemistry in 1992 and the PhD degree in physical chemistry in 1995.  From 1995 to 1997, Rogers was a Junior Fellow in the Harvard University Society of Fellows.  He joined Bell Laboratories as a Member of Technical Staff in the Condensed Matter Physics Research Department in 1997, and served as Director of this department from the end of 2000 to 2002.  He then spent thirteen years on the faculty at University of Illinois, most recently as the Swanlund Chair Professor and Director of the Seitz Materials Research Laboratory.  In the Fall of 2016, he joined Northwestern University as the Louis Simpson and Kimberly Querrey Professor, where he is also Director of the recently endowed Institute for Bioelectronics.  He is a member of the National Academy of Engineering, the National Academy of Sciences, the National Academy of Medicine, the National Academy of Inventors and the American Academy of Arts and Sciences.  
    Pr. Ipsita Roy
    Pr. Ipsita Roy, Professor of Biomaterials, Department of Materials Science and Engineering, University of Sheffield, is an expert in microbial biotechnology, natural biomaterials and their biomedical applications. Professor Roy was awarded the prestigious Inlaks Scholarship to study for her Ph.D. at the University of Cambridge, UK. At Cambridge, she was awarded scholarships including the Churchill College Scholarship and the Cambridge University Philosophical Society Fellowship Award. Her postdoctoral work was at the University of Minnesota, USA. She has published over 100 papers in high ‘Impact Factor’ journals such as Biomaterials, ACS Applied Materials Interfaces, with an H index of 40. Her group is focussed on the production of novel natural and sustainable polymers such as Polyhydroxyalkanoates, Bacterial cellulose and their biomedical and environmental applications. She is an editor of Scientific Reports and Biomedical Materials. Her total grant portfolio is more than 10 million pounds.
    Pr. Alberto Saiani
    Pr. Alberto Saiani is currently Professor of Molecular Materials at the University of Manchester. He graduated with a PhD in Polymer Physics from the University Louis Pasteur (Strasbourg, France). Subsequently, he held several post-doctoral positions in Japan, UK and Belgium before joining in 2002 the University of Manchester where he established the Polymers & Peptides Research Group (polymersandpeptides.co.uk). His work includes fundamental, industrial, and translational research and spans a wide area of experimental polymer and biopolymer science. In 2014 he co-founded a start-up company, Manchester BIOGEL (manchesterbiogel.com), which develops and commercialises advanced gel-based combination products for the life science and biomedical sector based on the technology developed in his group. 
    Dr. Jochen Salber
    Dr. Jochen Salber holds a PhD in polymer chemistry and biomedical sciences of the RWTH Aachen University (Germany) and is a board-certified orthopedic surgeon with 14 years of clinical experience working as emergency doctor and trauma surgeon. He is a full instructor of the European Resuscitation Council (ERC) and educates future ER specialists. Currently, he is head of the Department of Experimental Surgery at the Center for Clinical Research at the Ruhr University Bochum (RUB) and a senior physician at the Department of Surgery at the University Hospital RUB, Germany. His clinical interests are focused on Foreign Material-Associated Infections (FMAI), sepsis and multiple trauma immunology. His research group is working in the fields of clinically applied biomedical research with focus on biocompatibility assessment, tissue engineering and regenerative medicine. Refereed Journal Publications >60; h-index: 21; i10-index: 29; Citations: 1747; RG-score: 34.82
    Dr. Tiziano Serra
    Dr. Tiziano Serra is the Head of Sound Guided Tissue Regeneration Focus Area at AO Research Institute Davos, ARI. His team is focusing on the development of contactless biofabrication technologies, based on extrinsic fields, for modeling and regeneration. He received a MSc in Materials Science and Engineer from University of Salento (IT), a PhD at the Institute for Bioengineering of Catalonia (ES) and was postdoctoral fellow at University College London (UK). He was the recipient of the ISBF Young Investigator Award from the International Society of Biofabrication, BRIDGE Fellowship from SNSF-Innosuisse, and Julia Polak European Doctoral Award from European Society of Biomaterials. Tiziano is the inventor of Sound Induced Morphogenesis (SIM) technology and Chief Scientific Officer of mimiX Biotherapeutics.
    Pr. Maryam Tabrizian
    Pr. Maryam Tabrizian is full professor at the Biomedical Engineering Department and Faculty of Dental Medicine and Oral Health Sciences at McGill University. She holds a Canada Research Chair Tier I in Regenerative Medicine and Nanomedicine. She has received many prestigious awards and fellowships including the FRQS-Chercheur National, Guggenheim Foundation, Biomaterials Science & Engineering- International, RSC Academy of Sciences, ADEA Leadership Institute, the Canadian Academy of Health Sciences fellowships and James McGill professorship. Her research program is built on four main pillars: 1. Biomimetic materials for immunoengineering, angiogenesis and osteogenesis, 2. Nanoplexes tissue targeting and cell imaging, 3. Real-time monitoring of molecular and cellular events at biointerfaces, and 4. Microfluidics and Lab-on a-chip devices. M. Tabrizian has over 250 peer-reviewed publications with over 16700 citations and h-index of 67. She has been the Editor-in-Chief of Materials since 2011.
    Pr. Mark Tibbitt
    Pr. Mark Tibbitt joined ETH Zurich as an Assistant Professor of Macromolecular Engineering in the Department of Mechanical and Process Engineering in June 2017. Previously, he was an NIH Postdoctoral Fellow in the laboratory of Prof. Robert Langer in the Koch Institute for Integrative Cancer Research at the Massachusetts Institute of Technology. He received his B.A. in Integrated Science and Mathematics from Northwestern University, and his Ph.D. in Chemical Engineering at the University of Colorado Boulder under the supervision of Prof. Kristi S. Anseth. His research integrates concepts from chemical engineering, synthetic chemistry, materials science, and biology to rationally design and assemble soft matter. A recent focus of the lab has been on the design and understanding of dynamic polymer materials for biomedical applications, including as printable bioinks, injectable drug delivery systems, and viscoelastic 3D culture platforms.
    Dr. Nihal Engin Vrana
    Dr. Nihal Engin Vrana is CEO and co-funder of SPARTHA MEDICAL. He holds a B.Sc. (Biology) and a M.Sc. (Biotechnology) from Middle East Technical University and obtained his PhD in 2009 at Dublin City University as a Marie Curie ESR fellow. His major research interests are immunomodulatory and multifunctional coatings, medical implants, tissue engineering, biomaterial assessment and cell biomaterials interactions. He has coordinated several EU projects (BiMot, IMMODGEL and PANBioRA). He has published more than 100 peer reviewed articles and 7 book chapters, holds 6 patents and has edited 2 books. 
    Dr. Nathalie Weber 
    Dr. Nathalie Weber has been a clinical trial leader at Institut Straumann AG since 2018 where she manages clinical studies evaluating dental implant surfaces and regenerative dental biomaterials such as bone grafts, collagen membranes and enamel matrix derivative. She was previously a global product manager for five years at the same company responsible for the worldwide sales and marketing of a portfolio of regenerative dental biomaterials. Nathalie Weber holds a B.Sc. in Life Science and Technology from the Swiss Federal Institute of Technology in Lausanne (EPFL) and a M.Sc. in Biomedical Engineering from the Swiss Federal Institute of Technology in Zurich (ETH Zurich).
    Pr. Régine Willumeit-Römer 
    Pr. Régine Willumeit-Römer started her career as physicist specialized on ribosomal structure research. After her PhD in physics she habilitated in biochemistry and moved from the ribosome towards membrane active molecules such as peptide antibiotics. This was also the link to become interested in antibacterial implant surfaces and biomaterials as such. To date, as Director of the Institute of Materials Research, Division Metallic Biomaterials she is responsible for the development of degradable Mg-based implant materials.
    M. Francis Max Yavitt
    Francis Max Yavitt is a PhD Candidate in the lab of Dr. Kristi Anseth at the University of Colorado Boulder. He earned a B.Eng in Chemical Engineering with a minor in biosciences from McMaster University and a M.Sc. in Chemical Engineering from the University of Colorado Boulder. Generally, his research interests involve the development of novel hydrogel chemistries to study cellular mechanobiology. His current graduate research focuses on the use of photoadaptable hydrogels to investigate the role of mechanotransduction in intestinal organoid development. He was awarded an NIH F31 Predoctoral Fellowship to pursue this work. More information about his research contributions and interests can be found at https://www.colorado.edu/ansethgroup/ or on Twitter @LabMaxYav